BIOMAT Database Logo BIOMAT Database Logo

[Transcerebral electrophoresis of L-DOPA in the combined treatment of the hyperkinetic form of infantile cerebral palsy]. 1988

D A Kevlishvili, and L N Shubladze, and D A Kvitsaridze

The authors present a detailed description of transcerebral electrophoresis of L-DOPA conducted in 20 patients aged 9 months to 12 years suffering from a hyperkinetic form of childhood cerebral paralysis. Each patient received 10 sessions. The results of the treatment were assessed by a 5-point score system. Diminution of involuntary movements by 1 point was observed in 1 patient, by 2 points in 10 patients, by 3 points in 7 patients and by 4 points in 1 patient; in one case no positive results were noted. Muscular dystonia and the severity of tonic reflexes decreased in all patients; voluntary movements also improved. Treatment with transcerebral electrophoresis of L-DOPA was well tolerated and was not associated with side-effects.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007478 Iontophoresis Therapeutic introduction of ions of soluble salts into tissues by means of electric current. In medical literature it is commonly used to indicate the process of increasing the penetration of drugs into surface tissues by the application of electric current. It has nothing to do with ION EXCHANGE; AIR IONIZATION nor PHONOPHORESIS, none of which requires current. Iontophoreses
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D002547 Cerebral Palsy A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7) Diplegic Infantile Cerebral Palsy,Little Disease,Monoplegic Cerebral Palsy,Quadriplegic Infantile Cerebral Palsy,Spastic Diplegia,CP (Cerebral Palsy),Cerebral Palsy, Athetoid,Cerebral Palsy, Atonic,Cerebral Palsy, Congenital,Cerebral Palsy, Diplegic, Infantile,Cerebral Palsy, Dyskinetic,Cerebral Palsy, Dystonic-Rigid,Cerebral Palsy, Hypotonic,Cerebral Palsy, Mixed,Cerebral Palsy, Monoplegic, Infantile,Cerebral Palsy, Quadriplegic, Infantile,Cerebral Palsy, Rolandic Type,Cerebral Palsy, Spastic,Congenital Cerebral Palsy,Diplegia, Spastic,Infantile Cerebral Palsy, Diplegic,Infantile Cerebral Palsy, Monoplegic,Infantile Cerebral Palsy, Quadriplegic,Little's Disease,Monoplegic Infantile Cerebral Palsy,Rolandic Type Cerebral Palsy,Athetoid Cerebral Palsy,Atonic Cerebral Palsy,Cerebral Palsies, Athetoid,Cerebral Palsies, Dyskinetic,Cerebral Palsies, Dystonic-Rigid,Cerebral Palsies, Monoplegic,Cerebral Palsy, Dystonic Rigid,Cerebral Palsy, Monoplegic,Diplegias, Spastic,Dyskinetic Cerebral Palsy,Dystonic-Rigid Cerebral Palsies,Dystonic-Rigid Cerebral Palsy,Hypotonic Cerebral Palsies,Hypotonic Cerebral Palsy,Mixed Cerebral Palsies,Mixed Cerebral Palsy,Monoplegic Cerebral Palsies,Spastic Cerebral Palsies,Spastic Cerebral Palsy,Spastic Diplegias
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006257 Head The upper part of the human body, or the front or upper part of the body of an animal, typically separated from the rest of the body by a neck, and containing the brain, mouth, and sense organs. Heads
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D A Kevlishvili, and L N Shubladze, and D A Kvitsaridze
[Stereotaxic surgery in the hyperkinetic form of infantile cerebral palsy].
January 1976, Voprosy neirokhirurgii,
D A Kevlishvili, and L N Shubladze, and D A Kvitsaridze
[Treatment of the hyperkinetic form of cerebral palsy in children].
January 1975, Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952),
D A Kevlishvili, and L N Shubladze, and D A Kvitsaridze
[Changes in the clinical electromyographic indices of patients with the hyperkinetic form of infantile cerebral palsy and their dynamics during combined sanatorium-health resort treatment including transcerebral exposure to an ultrahigh-frequency electrical field].
January 1993, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
D A Kevlishvili, and L N Shubladze, and D A Kvitsaridze
[Hemiparetic form of infantile cerebral palsy].
September 1978, Ceskoslovenska neurologie a neurochirurgie,
D A Kevlishvili, and L N Shubladze, and D A Kvitsaridze
[Triparetic form of infantile cerebral palsy].
January 1974, Neurologia i neurochirurgia polska,
D A Kevlishvili, and L N Shubladze, and D A Kvitsaridze
[Experience with L-DOPA treatment of children with dystonia musculorum deformans and dystonic hyperkineses in infantile cerebral palsy].
January 1985, Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952),
D A Kevlishvili, and L N Shubladze, and D A Kvitsaridze
[Trans-cerebral electrophoresis of L-DOPA in the complex treatment of parkinsonism].
January 1984, Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952),
D A Kevlishvili, and L N Shubladze, and D A Kvitsaridze
[Handedness in diparetic form of infantile cerebral palsy].
January 1973, Neurologia i neurochirurgia polska,
D A Kevlishvili, and L N Shubladze, and D A Kvitsaridze
[Twins & infantile cerebral palsy: combined study].
August 1958, L'union medicale du Canada,
D A Kevlishvili, and L N Shubladze, and D A Kvitsaridze
[Orthopedic treatment of children with the diplegic form of infantile cerebral palsy].
December 1981, Ortopediia travmatologiia i protezirovanie,
Copied contents to your clipboard!